Lesbian, Gay,
Bisexual,
Transgender,
Intersex,
Queer &
Asexual People
Lesbian, Gay,
Bisexual, Transgender,
Intersex, Queer &
Asexual People

Lesbian, Gay, Bisexual, Transgender, Intersex, Queer, and Asexual (LGBTIQA+) People

The Lesbian, Gay, Bisexual, Transgender, Intersex, Queer, and Asexual (LGBTIQA+) community consists of people from many distinct groups, each with different needs and considerations.

There are no nationally available cancer datasets for LGBTIQA+ people; however, it is broadly estimated that 3.5%–11% of people in Australia are of diverse sexual or gender identity.[53]

People identifying as belonging to diverse populations may identify across multiple priority population groups. This intersectionality can result in compounding impacts of social, cultural, commercial and environmental determinants of health on cancer experiences and outcomes.

Current state

Certain cancers disproportionately affect LGBTIQA+ people, including breast, ovarian, and anal cancers.[54] Additionally, LGBTIQA+ people are more likely to avoid or delay participation with health services, including cancer screening programs, due to fear of discrimination and health professionals having inadequate knowledge and skills around inclusivity and the specific needs and preferences of LGBTIQA+ people.[55][56]

LGBTIQA+ people experience a disproportionate cancer burden and face unique challenges, such as higher rates of cancer-related distress and sexual concerns, lower levels of family support, poorer mental health, and more difficulties in accessing general health care or cancer services. LGBTIQA+ people also experience gaps in information when communicating with health providers and report lower levels of satisfaction with cancer care.[54][55][57][58]

LGBTIQA+ people continue to experience discrimination, harassment, and hostility in many parts of everyday life, including when accessing health services.[55][59]

Future state

The Australian Cancer Plan aims to create community-led partnerships to address inequities in cancer outcomes for LGBTIQA+ people. This includes designing targeted and inclusive screening programs, developing education and training regarding inclusive practices for healthcare providers, and developing co-designed cancer information that is relevant to LGBTIQA+ people and their unique needs. Improved data access and collection will inform measurement of cancer risk factors, cancer incidence, and cancer experiences among LGBTIQA+ people so they have better access to appropriate care and services across the cancer continuum.

Key Frameworks, Strategies, and Relevant Plans

Pride in our future: Victoria’s LGBTIQ+ strategy 2022–32

Year: 2022-32
Author: Department of Families, Fairness and Housing, State Government of Victoria

Pride in our future: Victoria's LGBTIQ+ Strategy 202232, provides the vision and plan to drive equality and inclusion for Victoria’s diverse lesbian, gay, bisexual, trans and gender diverse, intersex and queer (LGBTIQ+) communities within all aspects of government work over the next decade.

https://www.vic.gov.au/pride-our-future-victorias-lgbtiq-strategy-2022-32

NDIA LGBTIQA+ Strategy

Year: 2020
Author: National Disability Insurance Scheme, Australian Government

The National Disability Insurance Agency (NDIA) LGBTIQA+ Strategy seeks to address challenges and strengthen opportunities so that LGBTIQA+ people achieve the best outcomes from their National Disability Insurance Scheme (NDIS) plan.

https://www.ndis.gov.au/about-us/strategies/lgbtiqa-strategy

Actions to Support LGBTI Elders: A Guide for Aged Care Providers

Year: 2019
Author: Department of Health and Aged Care, Australian Government

The Actions to Support LGBTI Elders: A Guide for Aged Care Providers provides a strategy for aged care providers to deliver more inclusive services to lesbian, gay, bisexual, trans and gender diverse, and intersex elders.

https://www.health.gov.au/resources/publications/actions-to-support-lgbti-elders-a-guide-for-aged-care-providers

NSW LGBTIQ+ Health Strategy 2022–2027

Year: 2022
Author: NSW Ministry of Health, NSW Government

The NSW LGBTIQ+ Health Strategy 20222027 provides direction to all NSW Health organisations and staff to collectively deliver the best care to LGBTIQ+ people and work with them to achieve optimal health and wellbeing.

https://www.health.nsw.gov.au/lgbtiq-health/Pages/default.aspx

National Strategy for the Elimination of Cervical Cancer

Year: In development
Author: Australian Centre for the Prevention of Cervical Cancer

The National Strategy for the Elimination of Cervical Cancer will aim to eliminate cervical cancer for all people with a cervix across the diverse communities in Australia.

https://acpcc.org.au/elimination/

National Consultation on the Health and Wellbeing of LGBTIQ+ People

Year: 2023

The National Consultation on the Health and Wellbeing of LGBTIQ+ People will be undertaken in partnership with community-led organisations, LGBTIQA+ Health Australia (LHA) and the Australian Federation of AIDS Organisation (AFAO), to consult on the unique health and mental health issues and barriers to access and care faced by LGBTIQ+ Australians.

https://www.health.gov.au/ministers/the-hon-mark-butler-mp/media/minister-for-health-and-aged-care-and-assistant-minister-for-health-and-aged-care-press-conference-1-march-2023

Implementation considerations

Maximising cancer prevention and early detection
Enhanced consumer experience
World class health systems for optimal care
Strong and dynamic foundations
Workforce to transform the delivery of cancer care
Achieving equity in cancer outcomes for Aboriginal and Torres Strait Islander people

Stakeholder input

LGBTIQA+ people are at greater risk of specific cancers including breast and cervical cancers, but participation in cancer screening programs is low among this community.

Stakeholders proposed that LGBTIQA+ inclusivity, visibility, and knowledge in cancer prevention and screening programs (including ensuring transgender people are invited to access relevant targeted programs) is needed to increase LGBTIQA+ peoples’ participation in these programs.

2 Years
5 Years

Actions

1.2.1
Deliver cancer prevention and health promotion activities, including healthy lifestyles, immunisation, and population screening participation, co-designed and tailored to a range of settings.
  • Enhanced personalised risk assessment of different cancer types for LGBTIQA+ communities, including for breast, cervical, non-Hodgkin’s lymphoma, and anal cancers.
  • Inclusive screening programs and services for gender and sexuality diverse people, that are visibly inclusive and knowledgeable of LGBTIQA+ needs.
-
1.2.3
Promote translational research on the impact of social, cultural, commercial and environmental determinants of health on cancer outcomes for priority populations to inform policy and practice.
  • Improved collection of sexuality and gender-inclusive data in Australia to understand the impact of social, cultural, commercial, and environmental determinants on cancer outcomes for people in the LGBTIQA+ community.
-
1.2.4
Undertake ongoing assessment of the evidence for risk-based, cost-effective population cancer screening.
  • Risk-based, cost-effective population cancer screening to include predisposing risks that are unique to members of different groups within the LGBTIQA+ community.
  • Assessment of risk-based screening initiatives to ensure they can be delivered in a manner that is culturally sensitive to the needs, preferences, and considerations of LGBTIQA+ Australians.
-

2 Years

Actions

1.2.1
Deliver cancer prevention and health promotion activities, including healthy lifestyles, immunisation, and population screening participation, co-designed and tailored to a range of settings.
  • Enhanced personalised risk assessment of different cancer types for LGBTIQA+ communities, including for breast, cervical, non-Hodgkin’s lymphoma, and anal cancers.
  • Inclusive screening programs and services for gender and sexuality diverse people, that are visibly inclusive and knowledgeable of LGBTIQA+ needs.
-
1.2.3
Promote translational research on the impact of social, cultural, commercial and environmental determinants of health on cancer outcomes for priority populations to inform policy and practice.
  • Improved collection of sexuality and gender-inclusive data in Australia to understand the impact of social, cultural, commercial, and environmental determinants on cancer outcomes for people in the LGBTIQA+ community.
-
1.2.4
Undertake ongoing assessment of the evidence for risk-based, cost-effective population cancer screening.
  • Risk-based, cost-effective population cancer screening to include predisposing risks that are unique to members of different groups within the LGBTIQA+ community.
  • Assessment of risk-based screening initiatives to ensure they can be delivered in a manner that is culturally sensitive to the needs, preferences, and considerations of LGBTIQA+ Australians.
-

5 Years

Actions

1.5.3
Implement new, and improve existing, evidenced-based, risk-stratified cancer screening programs.
  • Risk-stratified cancer screening programs co-designed with LGBTIQA+ people to be inclusive and sensitive to the unique needs within the LGBTIQA+ community.
  • Delivery of co-designed targeted resources informing consumers of the risks that would make them eligible for screening.
-

Maximising cancer prevention and early detection

Stakeholder input

LGBTIQA+ people are at greater risk of specific cancers including breast and cervical cancers, but participation in cancer screening programs is low among this community.

Stakeholders proposed that LGBTIQA+ inclusivity, visibility, and knowledge in cancer prevention and screening programs (including ensuring transgender people are invited to access relevant targeted programs) is needed to increase LGBTIQA+ peoples’ participation in these programs.

2 Years
5 Years

Actions

1.2.1
Deliver cancer prevention and health promotion activities, including healthy lifestyles, immunisation, and population screening participation, co-designed and tailored to a range of settings.
  • Enhanced personalised risk assessment of different cancer types for LGBTIQA+ communities, including for breast, cervical, non-Hodgkin’s lymphoma, and anal cancers.
  • Inclusive screening programs and services for gender and sexuality diverse people, that are visibly inclusive and knowledgeable of LGBTIQA+ needs.
-
1.2.3
Promote translational research on the impact of social, cultural, commercial and environmental determinants of health on cancer outcomes for priority populations to inform policy and practice.
  • Improved collection of sexuality and gender-inclusive data in Australia to understand the impact of social, cultural, commercial, and environmental determinants on cancer outcomes for people in the LGBTIQA+ community.
-
1.2.4
Undertake ongoing assessment of the evidence for risk-based, cost-effective population cancer screening.
  • Risk-based, cost-effective population cancer screening to include predisposing risks that are unique to members of different groups within the LGBTIQA+ community.
  • Assessment of risk-based screening initiatives to ensure they can be delivered in a manner that is culturally sensitive to the needs, preferences, and considerations of LGBTIQA+ Australians.
-

2 Years

Actions

1.2.1
Deliver cancer prevention and health promotion activities, including healthy lifestyles, immunisation, and population screening participation, co-designed and tailored to a range of settings.
  • Enhanced personalised risk assessment of different cancer types for LGBTIQA+ communities, including for breast, cervical, non-Hodgkin’s lymphoma, and anal cancers.
  • Inclusive screening programs and services for gender and sexuality diverse people, that are visibly inclusive and knowledgeable of LGBTIQA+ needs.
-
1.2.3
Promote translational research on the impact of social, cultural, commercial and environmental determinants of health on cancer outcomes for priority populations to inform policy and practice.
  • Improved collection of sexuality and gender-inclusive data in Australia to understand the impact of social, cultural, commercial, and environmental determinants on cancer outcomes for people in the LGBTIQA+ community.
-
1.2.4
Undertake ongoing assessment of the evidence for risk-based, cost-effective population cancer screening.
  • Risk-based, cost-effective population cancer screening to include predisposing risks that are unique to members of different groups within the LGBTIQA+ community.
  • Assessment of risk-based screening initiatives to ensure they can be delivered in a manner that is culturally sensitive to the needs, preferences, and considerations of LGBTIQA+ Australians.
-

5 Years

Actions

1.5.3
Implement new, and improve existing, evidenced-based, risk-stratified cancer screening programs.
  • Risk-stratified cancer screening programs co-designed with LGBTIQA+ people to be inclusive and sensitive to the unique needs within the LGBTIQA+ community.
  • Delivery of co-designed targeted resources informing consumers of the risks that would make them eligible for screening.
-

Enhanced consumer experience

Stakeholder input

Stakeholders highlighted that LGBTIQA+ people have multiple identities that require unique healthcare navigation needs which are not currently addressed within the health system.

The LGBTIQA+ community experiences discomfort due to stigma and discrimination when accessing health care services. LGBTIQA+ people present late to health services and experience delays in diagnosis in response to these barriers.

Culturally appropriate care and services that reflect LGBTIQA+ peoples’ needs and preferences in a health system designed to respect and understand people’s unique circumstance will improve experiences and equitable outcomes. Healthcare professionals should be equipped to understand and support issues related to gender identity and sex, including use of preferred pronouns.

2 Years

Actions

2.2.1
Develop a national framework for and implement integrated multi-channel, multi-disciplined navigation models that ensure the right support at the right time for every consumer across the cancer continuum.
  • National navigation models co-designed in partnership with LGBTIQA+ people, organisations, and advocacy groups to ensure new models reflect the specific needs of individuals within this community.
-
2.2.2
Improve availability of co-designed, tailored information and care for consumers to improve health literacy and reduce cancer-related stigma.
  • Co-design tailored resources for the LGBTIQA+ community to build awareness of specific cancers and ease of navigation through the cancer system.
  • Promote culturally appropriate care and services for LGBTIQA+ people, such as psychosocial care, allied health care and financial planning advice support services.
  • Disseminate tailored resources for LGBTIQA+ people available on reputable and trusted cancer websites.
-

2 Years

Actions

2.2.1
Develop a national framework for and implement integrated multi-channel, multi-disciplined navigation models that ensure the right support at the right time for every consumer across the cancer continuum.
  • National navigation models co-designed in partnership with LGBTIQA+ people, organisations, and advocacy groups to ensure new models reflect the specific needs of individuals within this community.
-
2.2.2
Improve availability of co-designed, tailored information and care for consumers to improve health literacy and reduce cancer-related stigma.
  • Co-design tailored resources for the LGBTIQA+ community to build awareness of specific cancers and ease of navigation through the cancer system.
  • Promote culturally appropriate care and services for LGBTIQA+ people, such as psychosocial care, allied health care and financial planning advice support services.
  • Disseminate tailored resources for LGBTIQA+ people available on reputable and trusted cancer websites.
-

World class health systems for optimal care

Stakeholder input

LGBTIQA+ people face discrimination and culturally unsafe or inappropriate interactions in their cancer care. In particular, transgender people and people with intersex variations experience the highest levels of discrimination. Additionally, it was noted that LGBTIQA+ people have many unmet needs in their cancer care experience, including more limited access to follow-up care, and reluctance to discuss sexual health issues.

2 Years

Actions

3.2.1
Develop and implement a national framework that standardises the development, update, evaluation and uptake of Optimal Care Pathways (OCPs), including for priority population groups.
  • National framework that provides the specific treatment, support, and follow-up care needs of LGBTIQA+ consumers to ensure inclusive practices (e.g. language guides, inclusivity of intake forms and referral pathways to tailored supportive care services).
-
3.2.2
Develop a national framework for networked, distributed comprehensive cancer care, to facilitate provision of services as close as safely possible to where patients live. This will include the role of Comprehensive Cancer Centres to enhance patient outcomes, strengthen transparency and accountability, and drive continuous improvements for all patients across the network regardless of where the care is provided.
  • National framework for networked comprehensive cancer care co-designed with LGBTIQA+ people and advocacy groups to drive continuous improvements in their experience of care, recognising the unique needs and multiple identities of LGBTIQA+ people.
-
3.2.3
Implement innovative, evidence-based and cost-effective models of care for people living with and beyond cancer.

Innovative, evidence-based models of care that include multidisciplinary cancer care teams that address the additional challenges faced by LGBTIQA+ people (such as sexual health issues or psychological issues resulting from stigma).

-
3.2.4
Develop and refine integrated care models to maximise access to high-quality, timely and evidence-based palliative and end-of-life care, including voluntary assisted dying.
  • Integrated care models that expand access to culturally safe and responsive palliative care, advance care planning, end-of-life care and VAD services for LGBTIQA+ people.
  • Integrated care models that provide supportive services to help navigate challenges arising from LGBTIQA+ people often having chosen families and biological families (for example on questions of next of kin and wills).
-

2 Years

Actions

3.2.1
Develop and implement a national framework that standardises the development, update, evaluation and uptake of Optimal Care Pathways (OCPs), including for priority population groups.
  • National framework that provides the specific treatment, support, and follow-up care needs of LGBTIQA+ consumers to ensure inclusive practices (e.g. language guides, inclusivity of intake forms and referral pathways to tailored supportive care services).
-
3.2.2
Develop a national framework for networked, distributed comprehensive cancer care, to facilitate provision of services as close as safely possible to where patients live. This will include the role of Comprehensive Cancer Centres to enhance patient outcomes, strengthen transparency and accountability, and drive continuous improvements for all patients across the network regardless of where the care is provided.
  • National framework for networked comprehensive cancer care co-designed with LGBTIQA+ people and advocacy groups to drive continuous improvements in their experience of care, recognising the unique needs and multiple identities of LGBTIQA+ people.
-
3.2.3
Implement innovative, evidence-based and cost-effective models of care for people living with and beyond cancer.

Innovative, evidence-based models of care that include multidisciplinary cancer care teams that address the additional challenges faced by LGBTIQA+ people (such as sexual health issues or psychological issues resulting from stigma).

-
3.2.4
Develop and refine integrated care models to maximise access to high-quality, timely and evidence-based palliative and end-of-life care, including voluntary assisted dying.
  • Integrated care models that expand access to culturally safe and responsive palliative care, advance care planning, end-of-life care and VAD services for LGBTIQA+ people.
  • Integrated care models that provide supportive services to help navigate challenges arising from LGBTIQA+ people often having chosen families and biological families (for example on questions of next of kin and wills).
-

Strong and dynamic foundations

Stakeholder input

Increased data collection regarding sexuality and gender inclusivity, including in health surveys, registries, and patient records would improve understanding of the cancer care needs and lifestyle behaviours of this priority population group. Collection of this data would improve the measurement of cancer risk factors, cancer incidence, and cancer experiences among LGBTIQA+ people.

Stakeholders also pointed to the need to invest in research to better understand cancer risks and experiences of LGBTIQA+ people.


2 Years

Actions

4.2.1
Develop an agreed national cancer data framework to improve accessibility, consistency and comprehensiveness of integrated data assets.
  • Improved collection of sexuality and gender-inclusive data to better understand cancer trends and outcomes for LGBTIQA+ people.
-
4.2.2
Ensure targeted and innovative research investment into areas of unmet and emerging need; and improve clinical trial design and equitable access.
  • Prioritise targeted research to better understand cancer risks and experiences of LGBTIQA+ people.
  • Improve the collection of sexuality and gender-inclusive data for research purposes.
  • Co-design clinical trials with LGBTIQA+ people to ensure that they are culturally safe.
-
4.2.3
Identify opportunities to improve equitable cancer care through the digital health ecosystem.
  • Digital health ecosystem that promotes culturally safe digital cancer care services to LGBTIQA+ people who may face greater social stigma that prevents access to cancer care.
-

2 Years

Actions

4.2.1
Develop an agreed national cancer data framework to improve accessibility, consistency and comprehensiveness of integrated data assets.
  • Improved collection of sexuality and gender-inclusive data to better understand cancer trends and outcomes for LGBTIQA+ people.
-
4.2.2
Ensure targeted and innovative research investment into areas of unmet and emerging need; and improve clinical trial design and equitable access.
  • Prioritise targeted research to better understand cancer risks and experiences of LGBTIQA+ people.
  • Improve the collection of sexuality and gender-inclusive data for research purposes.
  • Co-design clinical trials with LGBTIQA+ people to ensure that they are culturally safe.
-
4.2.3
Identify opportunities to improve equitable cancer care through the digital health ecosystem.
  • Digital health ecosystem that promotes culturally safe digital cancer care services to LGBTIQA+ people who may face greater social stigma that prevents access to cancer care.
-

Workforce to transform the delivery of cancer care

Stakeholder input

Stakeholders identified the need for the cancer care workforce to better understand diagnostic and treatment needs of LGBTIQA+ people. Improved understanding of the needs of LGBTIQA+ people could reduce misinformation around screening participation (such as cervical screening for transgender people), stigma, and discrimination. Implementing regular LGBTIQA+ inclusion and diversity training for cancer care professionals would help to reduce such barriers and discrimination towards LGBTIQA+ people.

2 Years

Actions

5.2.1
Identify current and emerging workforce undersupply in line with cancer workforce modelling and other national health workforce strategies, and initiate planning with the sector towards building future workforce capacity and capability.
  • Model the distribution of cancer care practitioners trained in culturally safe and inclusive care and support of LGBTIQA+ people.
-
5.2.2
Build on existing capability of the primary care workforce to collaboratively and sustainably support the needs of consumers.
  • Collaborate with LGBTIQA+ networks and consumers to develop language and supportive care guides for GPs and other primary care staff.
  • Build capability of primary care workforce involved in cancer screening on culturally safe and inclusive screening and early detection services for LGBTIQA+ people.
-

2 Years

Actions

5.2.1
Identify current and emerging workforce undersupply in line with cancer workforce modelling and other national health workforce strategies, and initiate planning with the sector towards building future workforce capacity and capability.
  • Model the distribution of cancer care practitioners trained in culturally safe and inclusive care and support of LGBTIQA+ people.
-
5.2.2
Build on existing capability of the primary care workforce to collaboratively and sustainably support the needs of consumers.
  • Collaborate with LGBTIQA+ networks and consumers to develop language and supportive care guides for GPs and other primary care staff.
  • Build capability of primary care workforce involved in cancer screening on culturally safe and inclusive screening and early detection services for LGBTIQA+ people.
-

Achieving equity in cancer outcomes for Aboriginal and Torres Strait Islander people

The Australian Cancer Plan considers an intersectional and health equity approach for Aboriginal and Torres Strait Islander people. This is more than recognising the multiple backgrounds, experiences, and ways Aboriginal and Torres Strait Islander people identify. This approach addresses the way membership of multiple groups may impact people's health and wellbeing needs and ability to access care.

Implementation of each action should consider the compounding impacts of intersectionality across other priority population groups.

2 Years
5 Years

Actions

6.2.1
Embed Aboriginal and Torres Strait Islander voices in policymaking on cancer prevention, care delivery and standards through leadership, collaboration and co-design processes.
6.2.2
Strengthen collaboration with service providers, regulatory authorities and the Aboriginal and Torres Strait Islander cancer workforce to establish clear accountability for culturally safe care and compliance with national standards.
6.2.3
Establish and enhance collaborative partnerships with communities and Aboriginal and Torres Strait Islander-led organisations.

2 Years

Actions

6.2.1
Embed Aboriginal and Torres Strait Islander voices in policymaking on cancer prevention, care delivery and standards through leadership, collaboration and co-design processes.
6.2.2
Strengthen collaboration with service providers, regulatory authorities and the Aboriginal and Torres Strait Islander cancer workforce to establish clear accountability for culturally safe care and compliance with national standards.
6.2.3
Establish and enhance collaborative partnerships with communities and Aboriginal and Torres Strait Islander-led organisations.

5 Years

Actions

6.5.1
Establish ongoing place-based engagement with Aboriginal and Torres Strait Islander people to understand emerging needs across the cancer care continuum.
6.5.2
Implement strategies to embed culturally safe care within cancer-related services for Aboriginal and Torres Strait Islander people.

Print the plan